Molecular interactions mediating T cell antigen recognition.

Over the past decade, key protein interactions contributing to T cell antigen recognition have been characterized in molecular detail. These have included interactions involving the T cell antigen receptor (TCR) itself, its coreceptors CD4 and CD8, the accessory molecule CD2, and the costimulatory receptors CD28 and CTLA-4. A clear view is emerging of how these molecules interact with their ligands at the cell-cell interface. Structural and binding studies have confirmed that the proteins span small but comparable distances and that, overall, they interact very weakly. However, there have been important surprises as well: that TCR interactions with peptide-MHC are topologically constrained and characterized by considerable conformational flexibility at the binding interface; that coreceptors engage peptide-MHC with extraordinarily fast kinetics and at angles apparently precluding direct interactions with the TCR bound to the same peptide-MHC; that the structural mechanisms allowing recognition by costimulatory and accessory molecules to be weak and yet specific are very heterogeneous; and that because of differences in both binding affinity and stoichiometry, there is enormous variation in the stability of the various costimulatory receptor/ligand complexes. These studies provide the necessary framework for exploring how these molecular interactions initiate T cell activation.

[1]  S. Jameson,et al.  T-cell-receptor affinity and thymocyte positive selection , 1996, Nature.

[2]  A. Sharpe,et al.  The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. , 1999, Journal of immunology.

[3]  Gerhard Wagner,et al.  Structure of a Heterophilic Adhesion Complex between the Human CD2 and CD58 (LFA-3) Counterreceptors , 1999, Cell.

[4]  D. Littman,et al.  A kinase-independent function of Lck in potentiating antigen-specific T cell activation , 1993, Cell.

[5]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[6]  Michael Loran Dustin,et al.  Low Affinity Interaction of Human or Rat T Cell Adhesion Molecule CD2 with Its Ligand Aligns Adhering Membranes to Achieve High Physiological Affinity* , 1997, The Journal of Biological Chemistry.

[7]  Bernard Malissen,et al.  A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. , 2002, Immunity.

[8]  George F. Gao,et al.  Molecular coordination of αβ T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands , 2002 .

[9]  P. Anton van der Merwe,et al.  Topology of the CD2–CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells , 1995, Current Biology.

[10]  D. Kranz,et al.  Binding energetics of T-cell receptors: correlation with immunological consequences. , 1999, Immunology today.

[11]  M. Bachmann,et al.  Cd2 Sets Quantitative Thresholds in T Cell Activation , 1999, The Journal of experimental medicine.

[12]  Mary Collins,et al.  The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. , 2002, Annual review of immunology.

[13]  R. Karr,et al.  Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. , 1995, Journal of immunology.

[14]  D. Wiley,et al.  T Cell Receptor–MHC Interactions up Close , 2001, Cell.

[15]  M. Bennett,et al.  2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes , 2001, Immunological reviews.

[16]  Andrea Iaboni,et al.  The immunological synapse and CD28-CD80 interactions , 2001, Nature Immunology.

[17]  F. Chan,et al.  A role for the cytoplasmic tail of the β chain of CD8 in thymic selection , 1994 .

[18]  J. Altman,et al.  Role of CD8β Domains in CD8 Coreceptor Function , 2000 .

[19]  P. Linsley,et al.  CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics , 1997, The Journal of experimental medicine.

[20]  A. Smolyar,et al.  Structural Basis of CD8 Coreceptor Function Revealed by Crystallographic Analysis of a Murine CD8αα Ectodomain Fragment in Complex with H-2Kb , 1998 .

[21]  Margot Thome,et al.  The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/ζ complex , 1996, European journal of immunology.

[22]  Laurie H Glimcher,et al.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.

[23]  H. Ploegh,et al.  Peptide antagonism and T cell receptor interactions with peptide-MHC complexes. , 1998, Immunity.

[24]  S. Cusack,et al.  Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution. , 2000, Structure.

[25]  S. Almo,et al.  Structural mechanisms of costimulation , 2002, Nature Immunology.

[26]  M. McGregor,et al.  Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains , 1994, The Journal of experimental medicine.

[27]  A. Barclay,et al.  The hinge region of the CD8 alpha chain: structure, antigenicity, and utility in expression of immunoglobulin superfamily domains. , 1992, International immunology.

[28]  O. Acuto,et al.  Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex , 1995, The Journal of experimental medicine.

[29]  Partho Ghosh,et al.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.

[30]  L. Devine,et al.  Orientation of the Ig Domains of CD8αβ Relative to MHC Class I , 1999, The Journal of Immunology.

[31]  S. Almo,et al.  Structure of murine CTLA-4 and its role in modulating T cell responsiveness. , 2000, Science.

[32]  G. Gao,et al.  Killer Cell Immunoglobulin Receptors and T Cell Receptors Bind Peptide-Major Histocompatibility Complex Class I with Distinct Thermodynamic and Kinetic Properties* , 1999, The Journal of Biological Chemistry.

[33]  D. Wiley,et al.  Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. , 1998, Immunity.

[34]  A. Neil Barclay,et al.  2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48 , 1998, The Journal of experimental medicine.

[35]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[36]  P. Merwe,et al.  The immunological synapse: required for T cell receptor signalling or directing T cell effector function? , 2001, Current Biology.

[37]  K. Butenhof,et al.  Structure and dynamics of mucin-like glycopeptides. Examination of peptide chain expansion and peptide-carbohydrate interactions by stochastic dynamics simulations. , 1993, Biochemistry.

[38]  Mark M. Davis,et al.  Direct observation of ligand recognition by T cells , 2002, Nature.

[39]  Balbino Alarcón,et al.  Recruitment of Nck by CD3ϵ Reveals a Ligand-Induced Conformational Change Essential for T Cell Receptor Signaling and Synapse Formation , 2002, Cell.

[40]  L R Pease,et al.  Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Wiley,et al.  Structure of a covalently stabilized complex of a human αβ T‐cell receptor, influenza HA peptide and MHC class II molecule, HLA‐DR1 , 2000, The EMBO journal.

[42]  P. Linsley,et al.  Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. , 1994, Immunity.

[43]  A. Jamieson,et al.  Conformation of mucous glycoproteins in aqueous solvents , 1986, Biopolymers.

[44]  Ian A Wilson,et al.  Structural and thermodynamic correlates of T cell signaling. , 2002, Annual review of biophysics and biomolecular structure.

[45]  Ian A Wilson,et al.  The specificity of TCR/pMHC interaction. , 2002, Current opinion in immunology.

[46]  Z Reich,et al.  Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  E. Reinherz,et al.  Molecular dissection of the CD2-CD58 counter-receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional "hot spot". , 2001, Journal of molecular biology.

[48]  P. Merwe Leukocyte adhesion: High-speed cells with ABS , 1999, Current Biology.

[49]  B M Baker,et al.  Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. , 1999, Immunity.

[50]  Andrea Iaboni,et al.  The interaction properties of costimulatory molecules revisited. , 2002, Immunity.

[51]  B. Kaufman,et al.  Effects of deglycosylation on the architecture of ovine submaxillary mucin glycoprotein. , 1984, The Journal of biological chemistry.

[52]  C. Janeway The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. , 1992, Annual review of immunology.

[53]  Mark M. Davis,et al.  Two-step binding mechanism for T-cell receptor recognition of peptide–MHC , 2002, Nature.

[54]  S. Almo,et al.  Expression, refolding, purification, molecular characterization, crystallization, and preliminary X-ray analysis of the receptor binding domain of human B7-2. , 2002, Protein expression and purification.

[55]  D. Stuart,et al.  Crystal structure of the complex between human CD8αα and HLA-A2 , 1997, Nature.

[56]  B. Cocks,et al.  Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes , 1997, The Journal of experimental medicine.

[57]  A. Barclay,et al.  Transient intercellular adhesion: the importance of weak protein-protein interactions. , 1994, Trends in biochemical sciences.

[58]  P. Linsley,et al.  Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions* , 1996, The Journal of Biological Chemistry.

[59]  K. Garcia,et al.  Alanine Scanning Mutagenesis of an αβ T Cell Receptor: Mapping the Energy of Antigen Recognition , 1998 .

[60]  D. Littman,et al.  The cytoplasmic domain of CD8 beta regulates Lck kinase activation and CD8 T cell development. , 1998, Journal of immunology.

[61]  Mark I. Greene,et al.  Control of MHC Restriction by TCR Vα CDR1 and CDR2 , 1996, Science.

[62]  J. Guardiola,et al.  Identification of a CD4 binding site on the β2 domain of HLA-DR molecules , 1992, Nature.

[63]  Michael Loran Dustin,et al.  Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition. , 2000, Seminars in immunology.

[64]  R M Esnouf,et al.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.

[65]  D. Margulies,et al.  Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. , 1995, Journal of immunology.

[66]  K. Garcia,et al.  A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. , 2000, Immunity.

[67]  D. Leckband,et al.  Measuring the forces that control protein interactions. , 2000, Annual review of biophysics and biomolecular structure.

[68]  R. Zamoyska,et al.  The CD8 coreceptor revisited: one chain good, two chains better. , 1994, Immunity.

[69]  E. Reinherz,et al.  Developmentally Regulated Glycosylation of the CD8αβ Coreceptor Stalk Modulates Ligand Binding , 2001, Cell.

[70]  Ellis L. Reinherz,et al.  T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4* , 2001, The Journal of Biological Chemistry.

[71]  D. Wiley,et al.  Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling. , 2000, Immunity.

[72]  Direct measurements of heterotypic adhesion between the cell surface proteins CD2 and CD48. , 2002, Biochemistry.

[73]  G. Freeman,et al.  The B7–CD28 superfamily , 2002, Nature Reviews Immunology.

[74]  J. Bluestone,et al.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse , 1995, The Journal of experimental medicine.

[75]  J. Altman,et al.  CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. , 2001, Immunity.

[76]  K. Garcia,et al.  Structural basis of T cell recognition. , 1999, Annual review of immunology.

[77]  H. Irie,et al.  CD8 beta chain influences CD8 alpha chain-associated Lck kinase activity , 1995, The Journal of experimental medicine.

[78]  S. Davis,et al.  The Immunological Synapse--a Multitasking System , 2002, Science.

[79]  M. Lawrence,et al.  Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.

[80]  S. Davis,et al.  LICOS, a primordial costimulatory ligand? , 2000, Current Biology.

[81]  Z Reich,et al.  Ligand recognition by alpha beta T cell receptors. , 1998, Annual review of immunology.

[82]  B K Jakobsen,et al.  TCR binding to peptide-MHC stabilizes a flexible recognition interface. , 1999, Immunity.

[83]  Brian M. Baker,et al.  Identification of a Crucial Energetic Footprint on the α1 Helix of Human Histocompatibility Leukocyte Antigen (Hla)-A2 That Provides Functional Interactions for Recognition by Tax Peptide/Hla-A2–Specific T Cell Receptors , 2001, The Journal of experimental medicine.

[84]  E. Reinherz,et al.  Mechanisms Contributing to T Cell Receptor Signaling and Assembly Revealed by the Solution Structure of an Ectodomain Fragment of the CD3ϵγ Heterodimer , 2001, Cell.

[85]  D. Kioussis,et al.  T cell activation results in physical modification of the mouse CD8 beta chain. , 1994, Journal of immunology.

[86]  C. Chothia,et al.  Principles of protein–protein recognition , 1975, Nature.

[87]  D. Mason,et al.  Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. , 1994, Biochemistry.

[88]  C. Chothia,et al.  The atomic structure of protein-protein recognition sites. , 1999, Journal of molecular biology.

[89]  Gerhard Wagner,et al.  Structure, specificity and CDR mobility of a class II restricted single-chain T-cell receptor , 1999, Nature Structural Biology.

[90]  F. Wurm,et al.  CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. , 2001 .

[91]  B K Jakobsen,et al.  T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. , 1999, Immunity.

[92]  J. Strominger,et al.  Interaction between CD4 and class II MHC molecules mediates cell adhesion , 1987, Nature.

[93]  A. Sharpe,et al.  B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. , 1999, Journal of immunology.

[94]  F. Oliveri,et al.  Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor , 1992, Nature.

[95]  S. Bromley,et al.  The immunological synapse: a molecular machine controlling T cell activation. , 1999, Science.

[96]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[97]  K. Karjalainen,et al.  Mouse CD4 binds MHC class II with extremely low affinity. , 1993, International immunology.

[98]  S. Ikemizu,et al.  CD2 and the nature of protein interactions mediating cell‐cell recognition , 1998, Immunological reviews.

[99]  A. Fedorov,et al.  Structural basis for co-stimulation by the human CTLA-4/B7-2 complex , 2001, Nature.

[100]  D. Margulies,et al.  T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. , 1994, Science.

[101]  E. Reinherz,et al.  Expression, Purification, and Functional Analysis of Murine Ectodomain Fragments of CD8αα and CD8αβ Dimers* , 1999, The Journal of Biological Chemistry.

[102]  D. Aivazian,et al.  Phosphorylation of T cell receptor ζ is regulated by a lipid dependent folding transition , 2000, Nature Structural Biology.

[103]  E. Reinherz,et al.  Functional glycan‐free adhesion domain of human cell surface receptor CD58: design, production and NMR studies , 1999, The EMBO journal.

[104]  L R Pease,et al.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. , 1998, Science.

[105]  A. Alcover,et al.  Evidence for an extended structure of the T-cell co-receptor CD8 alpha as deduced from the hydrodynamic properties of soluble forms of the extracellular region. , 1993, The Journal of biological chemistry.

[106]  E A Merritt,et al.  Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.

[107]  P. Anton van der Merwe,et al.  The TCR Triggering Puzzle , 2001 .

[108]  A. O'Rourke,et al.  Activated CD8 binding to class I protein mediated by the T-cell receptor results in signalling , 1990, Nature.

[109]  Frits Koning,et al.  T Cell Responses Modulated Through Interaction Between CD8αα and the Nonclassical MHC Class I Molecule, TL , 2001, Science.

[110]  J. Strominger,et al.  Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. , 1998, Immunity.

[111]  K. Constantine,et al.  Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28 , 1997, Nature Structural Biology.

[112]  P. Parham,et al.  Cell-cell adhesion mediated by CD8 and MHC class I molecules , 1988, Nature.

[113]  Raimund J. Ober,et al.  Kinetics and thermodynamics of T cell receptor– autoantigen interactions in murine experimental autoimmune encephalomyelitis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[114]  D. Jeanfavre,et al.  Molecular regulation of the interaction between leukocyte function-associated antigen-1 and soluble ICAM-1 by divalent metal cations. , 1998, Journal of immunology.

[115]  Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[116]  R. J. Cohen,et al.  Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. , 1994, Immunity.

[117]  Michael Loran Dustin,et al.  Visualization of CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area , 1996, The Journal of cell biology.

[118]  S. Jameson,et al.  Role of 2c T Cell Receptor Residues in the Binding of Self–And Allo–Major Histocompatibility Complexes , 2000, The Journal of experimental medicine.

[119]  Ellis L. Reinherz,et al.  Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[120]  D. Mason,et al.  A very high level of crossreactivity is an essential feature of the T-cell receptor. , 1998, Immunology today.

[121]  A. Barclay,et al.  Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. , 2000, Immunity.

[122]  D. Fremont,et al.  High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. , 1998, Immunity.

[123]  A. Williams,et al.  Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[124]  Alexis M. Kalergis,et al.  Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex , 2001, Nature Immunology.

[125]  D I Stuart,et al.  Structure and dimerization of a soluble form of B7-1. , 2000, Immunity.

[126]  Yan Zhang,et al.  Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses , 2001, Nature.

[127]  D. Vestweber,et al.  Affinity, Kinetics, and Thermodynamics of E-selectin Binding to E-selectin Ligand-1* , 2001, The Journal of Biological Chemistry.

[128]  S. Davis,et al.  The role of charged residues mediating low affinity protein-protein recognition at the cell surface by CD2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[129]  A. Barclay,et al.  Affinity and kinetic analysis of the interaction of the cell adhesion molecules rat CD2 and CD48. , 1993, The EMBO journal.

[130]  David I. Stuart,et al.  Classical and Nonclassical Class I Major Histocompatibility Complex Molecules Exhibit Subtle Conformational Differences That Affect Binding to CD8αα* , 2000, The Journal of Biological Chemistry.

[131]  D I Stuart,et al.  Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. , 2000, The Journal of biological chemistry.

[132]  Yuzhe Xing,et al.  Small Molecule Ligands Define a Binding Site on the Immune Regulatory Protein B7.1* , 2002, The Journal of Biological Chemistry.

[133]  S. Davis,et al.  The structure and ligand interactions of CD2: implications for T-cell function. , 1996, Immunology today.